Join MIT Hacking Medicine as we bring the MIT Grand Hack to San Francisco! This is the weekend to brainstorm and build innovative solutions with hundreds of like-minded engineers, clinicians, designers, developers and business people. Within our multi-theme event, there is sure to be a healthcare challenge for everyone!
Interested in helping out? You can partner with us, become a sponsor, or sign up to be a mentor! Email firstname.lastname@example.org for more information!
Twitter Hashtag: #SFGrandHack2019
Watch and listen to the full video below from our MIT Grand Hack in Boston from April 2018!
With approximately 133M Americans (more than 40% of the US population) suffering from one or more chronic diseases, the healthcare community is looking for more effective and efficient ways to manage chronic diseases. Part of that pursuit is in finding sustainable ways to help patients better understand their conditions and manage their health by empowering patients, connecting them to information, care, and therapies in ways they want. Join fellow innovators to work on a challenging, multi-faceted, meaningful opportunity to advance clinical care, quality of life, and outcomes for nearly half the US. How can we improve patient literacy and clinical understanding? How do we help patients feel more in-control of their medical care? What can be done to help patients understand when and where they should seek care? These are just some of the pain points begging for thoughtful, tech-enabled solutions.
Many people around the world are limited in their access to necessary healthcare services, thereby increasing their risk of poor health outcomes and serious complications. These barriers to healthcare are out of the patient’s control, largely stemming from economic disparities, lack of education, and lack of availability of services in their geographical area. How can we work for these underserved populations to deliver basic healthcare needs? How do we make high demand health care services more easily accessible? What simple technologies can be set up to introduce clinical care at minimal cost? How can we bridge the gap between care at community hospitals, clinics, and in the home? This track will work together to ensure broader access to care for underserved populations to break down social, economic, and geographical barriers.
Whether directly or indirectly from depression, anxiety, OCD, PTSD, substance use, personality disorders, loneliness or burnout, millions of people live with a mental health condition. Join others in the mental health track & professional burnout track to tackle the broad range of pain points surrounding this complex field. How can we better detect, diagnose, and prevent these mental health conditions that often occur from professional settings? How can we help patients suffering from conditions such as PTSD improve their health? How can we continue to de-stigmatize mental health conditions and ensure that our society better accommodates for those who live with chronic mental health conditions? How can we ensure broader access to care, especially for vulnerable populations, and improve retention in treatment?
Dr. Jon Bloom is a board-certified physician and entrepreneur with over 15 years of experience in technology development, patient monitoring, biomedical research, and health care delivery. He is the chief executive officer of Podimetrics, a care management company with the leading solution to help prevent diabetic foot ulcers, one of the most debilitating and costly complications of diabetes. Dr. Bloom co-founded Podimetrics in 2011 while a student at the MIT Sloan School of Management. Podimetrics combines an FDA-cleared SmartMat™ with wraparound care management to spot signs of ulcers, on average, five weeks before they usually would present clinically. By combining cutting-edge technology with best-in-class care management, Podimetrics earns high engagement rates from patients and achieves unparalleled outcomes saving limbs, lives, and money. Dr. Bloom served as a Clinical Assistant Professor and staff anesthesiologist at the University of Pittsburgh Medical Center. He also served as the Director of Global Medical Affairs for Covidien’s Respiratory and Monitoring Solutions division in Boulder, Colorado. Dr. Bloom is a diplomate of the American Board of Anesthesiology, completing residency at the Massachusetts General Hospital. He has co-authored more than 20 peer-reviewed publications with a primary focus on health care economics and perioperative complications.
Arpa Garay is the current President of Global Pharma at Merck. Prior to this role, Arpa was Senior Vice President, US Vaccines, leading a team across the US to expand vaccine coverage to improve public health and deliver on business objectives, leading a team across the US to expand vaccine coverage to improve public health and deliver on business objectives. She was also the Managing Director of Norway, where she worked closely with the government on healthcare policy, developed innovative approaches to securing patient access, and led the subsidiary to become the #1 pharmaceutical company in the country. She brings to Merck extensive experience and success in strategic planning, marketing expertise, and collaborative management across a wide range of therapeutic areas and healthcare systems. She also brings with her a deep understanding of the US market and evolving global healthcare landscape. She has been externally recognized for her leadership as Fortune’s Most Powerful Women: Next Gen, Business Insider’s Global Top 30 under 40 in BioPharma, and Philadelphia Business Journal’s Top 40 under 40 business leaders. Arpa holds a Bachelor of Science in Economics from the Massachusetts Institute of Technology, where she focused on medicine, public health and public policy. She currently lives outside of Philadelphia with her husband and three children.
Dr. Thomas Osborne is the Director for the newly established VA National Center for Collaborative Healthcare Innovation (NCCHI) and is also the Chief Medical Informatics Officer (CMIO) at VA Palo Alto Healthcare System. He is currently leading multidisciplinary teams in the co-development of pioneering healthcare solutions with industry, government, and VA. His work has been published in numerous medical journals and textbooks with a focus on related topics such as artificial intelligence, predictive analytics, and the future of health care. Dr. Osborne received his medical degree from Dartmouth Medical School, completed his residency at Mount Auburn Hospital, and fellowship at Massachusetts General Hospital. He is board certified in both Diagnostic Radiology and Neuroradiology. Dr. Osborne is a staff neuroradiologist at VA Palo Alto Healthcare System and Clinical Assistant Professor (affiliated) at Stanford.
Matthew W. State MD, PhD, is a child psychiatrist and human geneticist studying pediatric neuropsychiatric syndromes. His lab focuses on gene discovery as a launching point for efforts to illuminate the biology of these conditions and to develop novel and more effective therapies. Dr. State received his undergraduate and medical degrees at Stanford University, completed his residency in psychiatry and fellowship in child psychiatry at the UCLA Neuropsychiatric Institute, and earned a PhD in genetics from Yale University working in the lab of David C Ward. He is currently the Oberndorf Family Distinguished Professor and Chair of Psychiatry at UCSF and Director of the Langley Porter Psychiatric Institute and Hospital. Dr. State’s lab has played a leading role in demonstrating the contribution of rare and de novo variation to autism spectrum disorders (ASD), Tourette disorder (TD), and brain malformation syndromes. Recent work has contributed to the identification of dozens of ASD risk genes, the identification of the first high confidence TD genes, and has utilized systems biological approaches to characterize the spatial and temporal convergence of autism genes in developing human brain. Dr. State plays a leadership role in a number of national and international collaborative genomics studies of autism and Tourette disorder, including the Simons Simplex Collection Genomics Consortium, the Autism Sequencing Consortium, and the Tourette International Collaboration (TIC) on Genetics.
complementary incorporation package (up to 8 hours of legal support), IP consultation and pitch deck coaching. The teams will get access to all UCSF Rosenman Institute events, including office hours, seminars and workshops, as appropriate.
This prize is awarded to the team whose service/product advances the patient value of ambulatory care (higher quality, better patient experience, lower cost) and/or help reduce provider burnout in the outpatient setting.
Atrius Health is a primary care based, multi-specialty delivery system with over 1100 clinicians serving over 700,000 patients across eastern Massachusetts. We are a national leader in population health management and value based care with a vision of transforming care to improve lives.
Schedule subject to change. Check back regularly for more details!
|5:00 PM||Registration opens|
|7:00 PM||Event kickoff – Opening presentations|
|9:00 PM||Breakout participant pitching session|
|10:00 PM||Team formation|
|11:00 PM||Friday events end|
|9:00 AM||Saturday Kick-off|
|12:00 PM||Team Registration|
|7:00 PM||Practice Pitches|
|10:00 PM||Formal event ends|
|9:00 AM||Practice Pitches|
|1:00 PM||Final Presentations (3 min presentations + 2 min Q&A)|
|3:30 PM||Prizes presented|
|5:00 PM||Event ends|